ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,552.40
-6 (-0.39%)
BSENSE

Dec 05

BSE+NSE Vol: 35.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryERIS Lifescience VS Pharmaceuticals & Biotechnology
 
1D
-0.39%
0.36%
1W
-2.69%
-0.16%
1M
-2.95%
2.53%
YTD
13.4%
9.51%
1Y
6.99%
4.65%
3Y
135.32%
36.18%
5Y
192.8%
89.82%
10Y
%
233.77%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.47%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.06%
0%
-10.06%
6 Months
-5.92%
0%
-5.92%
1 Year
6.99%
0.49%
7.48%
2 Years
69.01%
0.83%
69.84%
3 Years
135.32%
1.11%
136.43%
4 Years
119.98%
2.14%
122.12%
5 Years
192.8%
3.57%
196.37%

Latest dividend: 7.35 per share ex-dividend date: Feb-13-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-1.89%
2
Quartile
quartile-2
Jun-Sep
-5.49%
2
Quartile
quartile-2
Mar-Jun
19.11%
1
Quartile
quartile-1
YTD
7.4%
3
Quartile
quartile-3
2024
50.33%
3
Quartile
quartile-3
2023
41.07%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Good Performer

ERIS Lifesciences Ltd has been in the First and Second Quartile in the YTD and longer periods

2
Quartile
quartile-2
QTD
-1.89%
2
Quartile
quartile-2
Jun-Sep
-5.49%
2
Quartile
quartile-2
Mar-Jun
19.11%
1
Quartile
quartile-1
YTD
7.4%
2
Quartile
quartile-2
2024
50.33%
2
Quartile
quartile-2
2023
41.07%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-1.89%
2
Quartile
quartile-2
Jun-Sep
-5.49%
2
Quartile
quartile-2
Mar-Jun
19.11%
1
Quartile
quartile-1
YTD
7.4%
2
Quartile
quartile-2
2024
50.33%
3
Quartile
quartile-3
2023
41.07%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available